Monday, June 15, 2026

Celltrion’s 1 Trillion KRW Investment: A Game Changer for Biopharmaceutical Production by 2030

Celltrion plans a major expansion with over 1 trillion KRW investment, boosting production capacity for biosimilars and new drugs by 2030.

U.S.-Korea Nuclear Submarine Deal: What to Expect from February Delegation?

The U.S. will send a delegation to South Korea to discuss nuclear cooperation, submarines, and shipbuilding agreements by February.

Tag: Capital Markets Act

No posts to display

Top News

- Our Sponsors Ad -

Follow us